A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/538 (2006.01) A61K 9/22 (2006.01) A61K 9/36 (2006.01) A61P 25/06 (2006.01) A61P 25/16 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2621266
The present invention provides pharmaceutical compositions comprising a glucuronate salt of a piperazine compound, useful as a modulation of one or more GPCRs. In general, this salt form, and pharmaceutically acceptable compositions thereof, is useful for treating or lessening the severity of a variety of diseases or disorders including Parkinson's disease, stress/anxiety, Alzheimer's disease, Huntington's disease, panic disorders, obsessive compulsive disorder, eating disorders, drug addiction, social phobias, aggression or agitation, migraine, scleroderma and Raynaud's phenomenon, emesis, a Gl tract disorder related to the regulation of peristalsis, RLS, or prolactin secretion arising from tumours of the pituitary gland.
La présente invention concerne des compositions à libération prolongée utiles et des procédés destinés à les utiliser.
Ali Kadum
Diorio Christopher R.
Ehrnsperger Eric C.
Fawzi Mahdi B.
Shah Syed Muzafar
Fetherstonhaugh & Co.
Solvay Pharmaceuticals B.v.
LandOfFree
Sustained-release formulation comprising a glucuronate salt... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained-release formulation comprising a glucuronate salt..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release formulation comprising a glucuronate salt... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1608897